PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dalteparin sodium - Pre-operative / bridging therapy
PAD Profile : Dalteparin sodium - Pre-operative / bridging therapy
Keywords :
Low Molecular Weight Heparins, LMWH
Brand Names Include :
Fragmin
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- VTE prevention post hip/knee replacement
- VTE prophylaxis
- VTE treatment in patients unable to take oral anticoagulants
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
28 April 2010
Not Set
The committee were informed that pre-operative LMWH is included within the PbR tariff and should therefore be prescribed/provided by the acute trusts. It should be noted that private patients should not receive care that is different to that of NHS patients and on that principle, the pre-operative LMWH should form part of that patients' private care
Associated BNF Codes
02. Cardiovascular System
02.08.01. Parenteral anticoagulants